MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Press releases

Stay current with the latest press releases from within the industry.

CHI's Genome Tri-Conference 2002…The Molecular Medicine Marketplace

Release issued 11th January 2002

Media Alert for February 23 to March 1, 2002

Cambridge Healthtech Institute's Genome Tri- Conference To Attract Leading Experts as the Convergence of Genomics and Drug Discovery Transforms the Pharmaceutical Business

What: CHI's Genome Tri-Conference 2002…The Molecular Medicine Marketplace

Genomics is revolutionizing the drug discovery & development process. Learn about cutting-edge breakthroughs and applications at this weeklong event that includes programs on Genomic Partnering, Human Genome Discovery, and Gene Functional Analysis. The main exhibit hall with over 160 organizations is already sold out.

We invite members of the media to participate in the event, where you will interact with experts in genomics, proteomics, and bioinformatics. Representatives from leading pharmaceutical and biotech organizations, as well as government and academic institutions will be on hand.

When: Saturday, February 23 through Friday, March 1

Where: Santa Clara Convention Center 5001 Great America Parkway Santa Clara, California

Featured Presentations at the Genome Tri-Conference include:

At Genomic Partnering (February 23-24, 2002): Dr. Noubar B. Afeyan, Senior Managing Director and CEO, Flagship Ventures G. Steve Burrill, Chief Executive Officer, Burril & Company

At Human Genome Discovery (February 25-27, 2002): Dr. Lee Babiss, Head, Preclincial Research & Development, Hoffmann-La Roche, Inc. Dr. Maynard V. Olson, Professor of Genetics, University of Washington Dr. Leroy Hood, President and Director, Institute for Systems Biology Dr. Mihael Polymeropoulos, Novartis Pharmaceuticals Dr. Robert L. Strausberg, Director, Cancer Genomics Office, National Cancer Institute Dr. Andrew Lyall, IT Director and Chief Information Officer, Oxford GlycoSciences

At Gene Functional Analysis (February 28 - March 1, 2002): Dr. David Eisenberg, Director, U.S DOE Laboratory of Structural Biology and Molecular Medicine, Molecular Biology Institute, University of California, Los Angeles Dr. Karl K. Johe, Chairman and Chief Scientific Officer, Neuralstem, Inc.

Press Registration: By phone at 617-630-1300 or via the official event website www.genometriconference.com (click on press information). For additional information, event details, or to arrange interviews, please contact Dawn Peters at 617-630-1342

Company details

If you want to find out more about the company visit Cambridge Healthtech Institute profile.

Latest Cambridge Healthtech Institute press releases

More Press Releases

Clients in focus...

Get the Flash Player to see this rotator.

Partnering discussion free of charge
BioTrinity
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us